Spots Global Cancer Trial Database for Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy

Official Title: Comparison Between Short and Long Schemes of Antibiotic Prophylaxis for Transrectal Prostate Biopsy. A Multicentre Prospective Randomised Study

Study ID: NCT00294749

Conditions

Men Who Must Undergo a Prostate Biopsy Related to Prostate Cancer Suspicion.

Interventions

Ciprofloxacine

Study Description

Brief Summary: The purpose of this study is to determine whether long antibiotic prophylactic is more effective than a short traitement in infective complications for prostate biopsy

Detailed Description: Prophylactic antibiotic is used to minimize the infective complications risk following transrectal biopsy of the prostate. The majority of works points to the need of antibiotic prophylaxis previously to transrectal prostate biopsy. However, there is a lot of controversy and diversity of therapeutic schemes in the literature concerning the ideal drug to be used and the time employed for infectious prophylaxis. The objective of this randomised study was to assess 2 different schemes of antimicrobial prophylaxis, aiming to determine the difference in infective complications with a single dose of ciprofloxacin 2 hours before the procedure vs. ciprofloxacin for 3 days